Immediate Past Chair: Geert Cauwenbergh, Ph.D.

Phases 123 LLC,  Managing Director

Dr. Cauwenbergh founded Phases 123 LLC, a company focused on identifying high potential health care technology platforms and emerging health care companies.

In 2001, Dr. Cauwenbergh founded Barrier Therapeutics, Inc., a company developing novel patented therapeutic agents for treatment of skin diseases. Under his leadership, Barrier Therapeutics went public and raised a total of $250 million in capital, evolving from an R&D organization into a commercial company with expected revenues of $45 million in 2008, prior to its recent acquisition by Stiefel Laboratories. RHEI Pharmaceuticals (RHEI) of Plainsboro, NJ, is a specialty pharmaceutical company focused on bringing core medicines from the U.S., Europe and Japan, into the fast-growing marketplace in China.